CAZ Investments raises a $29 million round to back commercialized medical firms.
CAZ Investments raised a nearly $29 million funding round it plans to use to back medical companies that already have products on the market.
The Houston-based asset management firm reeled in $28.7 million from 61 unnamed investors, according to a regulatory filing.
CAZ Investments chairman Christopher Zook said the firm plans to use the cash to invest in commercialized companies.
"For this fund, we don't have as long a lag time. Typically, when you make a venture capital investment it's a concept and you have to wait for it to go through the entire process. We're investing only in products in the marketplace already generating revenue," Zook told the International Venture Capital Post.
Will new SEC rules kill angel investing?
New rules adopted by the SEC could threaten angel investing in startups, according to the Angel Capital Assn., including a ban on self-accreditation by potential investors.
Here's a look at some of the top funding stories for medical device companies this week.
FDA officials warn against the use of "laparoscopic power morcellation" for the removal of uterine...
Bio-artificial liver maker Vital Therapies takes its IPO even lower, now planning to open at $12 per...
California surgical devices maker Cardica details a public offering of common and preferred stock...